121 related articles for article (PubMed ID: 30611870)
21. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
Lam YM; Chan YF; Chan LC; Ng RK
Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
[TBL] [Abstract][Full Text] [Related]
22. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.
Vulcano F; Ciccarelli C; Mattia G; Marampon F; Giampiero M; Milazzo L; Pascuccio M; Zani BM; Giampaolo A; Hassan HJ
Exp Cell Res; 2006 May; 312(9):1590-7. PubMed ID: 16739251
[TBL] [Abstract][Full Text] [Related]
23. Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity.
Valente S; Tardugno M; Conte M; Cirilli R; Perrone A; Ragno R; Simeoni S; Tramontano A; Massa S; Nebbioso A; Miceli M; Franci G; Brosch G; Altucci L; Mai A
ChemMedChem; 2011 Apr; 6(4):698-712. PubMed ID: 21374822
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
Duncan HF; Smith AJ; Fleming GJ; Cooper PR
J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells.
Huynh NC; Everts V; Pavasant P; Ampornaramveth RS
J Cell Biochem; 2016 Jun; 117(6):1384-95. PubMed ID: 27043246
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of human cord blood CD34+ hematopoietic stem cell differentiation to megakaryocyte on aminated PES nanofiber scaffold compare to 2-D culture system.
Sabaghi F; Shamsasenjan K; Movasaghpour AA; Amirizadeh N; Nikougoftar M; Bagheri N
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1062-8. PubMed ID: 25761536
[TBL] [Abstract][Full Text] [Related]
29. Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells.
Hennig D; Müller S; Wichmann C; Drube S; Pietschmann K; Pelzl L; Grez M; Bug G; Heinzel T; Krämer OH
Br J Cancer; 2015 Jan; 112(2):329-37. PubMed ID: 25514379
[TBL] [Abstract][Full Text] [Related]
30. Analyzing the Impact of Pan- and Class-Specific HDACi on Differentiation-Associated Factors.
Noack K; Krämer OH
Methods Mol Biol; 2017; 1510():375-385. PubMed ID: 27761836
[TBL] [Abstract][Full Text] [Related]
31. CDDO-Im is a stimulator of megakaryocytic differentiation.
Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
[TBL] [Abstract][Full Text] [Related]
32. Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics.
Geeleher P; Loboda A; Lenkala D; Wang F; LaCroix B; Karovic S; Wang J; Nebozhyn M; Chisamore M; Hardwick J; Maitland ML; Huang RS
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26296641
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of histone deacetylases inhibitors and resveratrol on Trypanosoma cruzi replication, differentiation, infectivity and gene expression.
Campo VA
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):23-33. PubMed ID: 28038431
[TBL] [Abstract][Full Text] [Related]
34. LC3B-II deacetylation by histone deacetylase 6 is involved in serum-starvation-induced autophagic degradation.
Liu KP; Zhou D; Ouyang DY; Xu LH; Wang Y; Wang LX; Pan H; He XH
Biochem Biophys Res Commun; 2013 Nov; 441(4):970-5. PubMed ID: 24220335
[TBL] [Abstract][Full Text] [Related]
35. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW
Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160
[TBL] [Abstract][Full Text] [Related]
36. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.
Pai JT; Hsu CY; Hua KT; Yu SY; Huang CY; Chen CN; Liao CH; Weng MS
Molecules; 2015 May; 20(5):8000-19. PubMed ID: 25946558
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A
Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013
[TBL] [Abstract][Full Text] [Related]
38. Large generation of megakaryocytes from serum-free expanded human CD34+ cells.
Chen TW; Yao CL; Chu IM; Chuang TL; Hsieh TB; Hwang SM
Biochem Biophys Res Commun; 2009 Jan; 378(1):112-7. PubMed ID: 19010306
[TBL] [Abstract][Full Text] [Related]
39. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
Kollar J; Frecer V
J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
